Image

Masimo has received CE Mark approval for its Radius-7, the first rainbow signal extraction technology (SET) based noninvasive wearable, wireless monitor for Root patient monitoring and connectivity platform.

The company has also announced the limited market release of Radius-7, claimed to allow early identification of clinical deterioration, while offering patients continuous monitoring with freedom of movement.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Featuring rainbow SET technology, Radius-7 with Root alerts clinicians at the bedside or remotely, through the Masimo Patient SafetyNet remote monitoring and notification system.

Radius-7 can be attached to patient’s arm or can be placed alongside the patient’s bet for continuous monitoring.

The device can give alerts about critical changes in a patient’s oxygen saturation, pulse rate, respiration rate, or haemoglobin that may indicate pulmonary, cardiac, or internal bleeding problems.

"Radius-7 allows untethered clinically relevant patient monitoring."

With no need to disconnect and reconnect the cable to get out of bed, the device reduces the need for nursing assistance.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Radius-7 is connected through Bluetooth back to Root or with upgradeable WiFi for long-range communication, ensuring that the patients are monitored continuously and connected to the caregivers.

Masimo founder and CEO Joe Kiani said: "In the past, wearable patient monitoring offered only limited measurements that were often plagued by false alarms.

"Radius-7 allows untethered clinically relevant patient monitoring.

"We expect Radius-7 and Root to change how hospitals think about monitoring, ushering in a new level of patient safety."

Currently, Radius-7 is not available for sale in the US.


Image: The Radius-7 offers continuous, noninvasive patient monitoring with comfort and freedom of movement. Photo: courtesy of Marketwired/ Masimo.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
SC MEDICA’s minimally invasive, radiation free spinal facet fixation system, FFX® is transforming spinal pain management and improving outcomes for surgeons and patients alike. Learn how SC MEDICA’s award-winning technology is redefining standards in facet joint pain treatment.

Discover the Impact